Key Takeaways
- Oura's IPO is about four times oversubscribed: investors placed orders for roughly four times the 50 million shares on offer, according to Bloomberg. The deal prices today (29 September) and shares are expected to start trading on the Nasdaq (ticker: OURA) this week.
- The biggest IPO since Jersey Mike's in July: after a quiet September for new listings, Oura is set to be the first US IPO to raise more than $1 billion since the sandwich chain Jersey Mike's Subs debuted in July, so Wall Street is treating it as a test of appetite for new stocks.
- What "oversubscribed" means, and doesn't: more demand than shares, which usually pushes the price to the top of the range and means most ordinary investors won't get shares at the IPO price. It doesn't guarantee a pop or long-term returns: plenty of oversubscribed IPOs soared on day one and sagged later. Demand tells you about the deal, not the business.
- Why the demand: Oura arrives profitable ($61 million of net income over nine months), with fast-growing subscription revenue, 5 million paid members and big-name backers, rare for a consumer-hardware listing.
- The catches remain: 73% of the shares are existing investors cashing out, profitability is recent and thin, the valuation is rich, and IPOs are volatile. OURA is an example to research, not a recommendation. This is educational, not investment advice.
- Buy it your way: once OURA starts trading on the Nasdaq, you'll be able to buy Oura shares on Nemo.money from just $1 with zero commission, alongside global stocks and ETFs.
The smart-ring maker's stock-market debut has become the most in-demand listing of the autumn. Oura's initial public offering has drawn roughly four times as many orders as there are shares available, Bloomberg reported, and the banks running the deal stopped taking orders on Monday afternoon. The IPO prices today, with trading on the Nasdaq expected to follow this week. After a quiet September for new listings, it's set to be the first US IPO to raise more than $1 billion since sandwich chain Jersey Mike's Subs debuted in July, so Wall Street is watching it as a test of appetite for new stocks.
"Everyone wants in" is a great headline. But what does four-times demand actually mean for you, and what doesn't it mean? This guide explains oversubscription, why Oura is drawing the crowd, and the honest catches that haven't gone anywhere. (For the background, see our earlier pieces on what a hot IPO really means and the IPO terms and Eli Lilly's backing.) If it prompts you to research the theme, you can explore global stocks and ETFs from just $1 with zero commission on the Nemo.money app.
People are searching:
- "Oura IPO"
- "Oura IPO oversubscribed"
- "how to buy Oura stock"
- "buy Oura shares UAE"
- "Oura stock Nemo"
- "OURA stock price"
- "OURA ticker"
- "Oura IPO date"
- "Oura IPO price"
- "is Oura profitable"
- "Oura stock vs Whoop"
- "biggest IPO 2026"
- "IPO market September 2026"
- "what does oversubscribed mean IPO"
What's Happening This Week
The facts, as reported:
- 📈 Four times the orders. Investors placed orders for about four times the 50 million shares on offer, people familiar with the deal told Bloomberg. The order book closed on Monday afternoon (28 September).
- 🗓️ Pricing today, trading this week. Oura is scheduled to set its final IPO price on Tuesday 29 September, with shares expected to begin trading on the Nasdaq Global Select Market under the ticker OURA shortly after.
- 💵 The terms going in. 50 million shares at a marketed range of $40-44, raising up to about $2.2 billion, for a fully diluted valuation of roughly $15 billion at the top of the range. Only 13.5 million shares are new; 36.5 million (73%) are being sold by existing investors such as Forerunner Ventures and Lifeline Ventures.
- 🏦 Anchor investors. Eli Lilly has indicated interest in up to $100 million of shares and Dragoneer up to $300 million, about a fifth of the deal, though indications of interest aren't binding commitments.
- 📅 A quiet month, a big deal. September has been unusually quiet for US IPOs, with no listing raising more than $1 billion since Jersey Mike's Subs in July, according to Bloomberg data. Oura breaks that lull, which is why its reception is being read as a signal for the wider IPO market, even though 2026 overall is pacing as the strongest year for IPOs since 2021, powered by SpaceX's record $75 billion listing in June, with Anthropic and OpenAI both reportedly heading for mega-listings of their own.
- 🌐 Retail is unusually involved. Coinbase opened IPO allocations to US retail investors starting with this deal, and Robinhood and SoFi are offering access, part of why the demand feels so broad.
What "Oversubscribed" Actually Means
This is the concept worth understanding, because it's routinely misread.
- 🎟️ More demand than shares. In an IPO, the company and its banks offer a fixed number of shares. "Four times oversubscribed" means investors asked for roughly four times that number. It's a measure of demand for the deal, at the marketed price range.
- ⬆️ It usually lifts the price. When a book is heavily covered, the banks typically price at the top of the range or above it, and sometimes add shares. That's good for the sellers (Oura and the insiders cashing out), because they raise more money per share.
- 🧩 It means most people don't get shares. With four times the demand, allocations get cut. Big institutions and anchor investors get most of the stock; the retail investors who signed up through brokerage apps typically receive only a fraction of what they requested, or nothing. Many end up buying in the open market on day one instead, at whatever price the stock opens.
- 🔮 It says little about the long run. Oversubscription measures excitement on pricing day. It doesn't measure whether the business will grow into its valuation. Some of the most oversubscribed IPOs in history opened with huge pops and then spent years below their debut price; others opened quietly and did well. Even SpaceX's record listing, which jumped 19% on day one, showed how much of a debut is about sentiment. Demand is not a forecast. (Our IPO 101 guide covers how new listings tend to perform over time.)
Why Everyone Wants In
The enthusiasm isn't random. A few things set Oura apart from most consumer-hardware listings:
- 💰 It's already profitable. Oura reported $60.8 million of net income on $1.21 billion of revenue for the nine months to June 2026, with $71 million of operating income and $328 million of operating cash flow. That's unusual for a gadget company at IPO. (You may see a "$924 million loss" in some headlines: that's an accounting charge from repurchasing early investors' preferred stock before the IPO, not an operating loss.)
- 🔁 Subscriptions are the story. Membership revenue grew 121% year on year to $240 million, at an ~89% gross margin, and over 94% of ring buyers convert to paid members. Investors love recurring revenue, and Oura's CEO has pitched it as "a subscription company that happens to sell hardware."
- 📊 The growth numbers. Revenue up 74%, 5 million paid members (up ~100%), roughly 85% retention, and Oura now expects 5.7 million members by year-end. It also holds around 79% of the global smart-ring market.
- 🧬 Health-tech crossover. Eli Lilly's involvement, and more than 1,200 integrations with health partners, position Oura as a health-data platform rather than just a ring, a narrative that appeals to investors who missed the wearables wave the first time.
- 📅 The calendar helped. A thin September pipeline, with nothing over $1 billion since Jersey Mike's in July, meant Oura had the stage largely to itself, concentrating attention (and pent-up demand) on one deal.
What to Watch at the Debut
If you're following the listing, here's what actually matters, and OURA is an example to research, not a recommendation:
- 💵 The final price. Above the $44 top of the range would confirm the strength of demand, and raise the bar the business has to clear.
- 🎢 The opening trade vs the IPO price. A big first-day "pop" makes headlines but mostly rewards those who got IPO-price allocations. If you're buying in the open market, the question is whether the opening price makes sense against the fundamentals, not whether it's higher than the IPO price. (Once trading begins, OURA will be available to buy on Nemo.money from $1, so you can start with a small position rather than a full share.)
- 🔒 Lock-up expiry. Insiders typically can't sell for about 180 days. When that window opens, more supply can hit the market, a date worth noting given how many existing holders are already selling.
- 📈 The first earnings report. The real test is whether subscription growth stays above 100% and margins hold up once Oura reports as a public company.
- 🧪 The IPO market signal. Because this is the first $1 billion-plus US IPO since Jersey Mike's in July, a strong debut may encourage other companies to list, and a weak one may suggest sentiment is turning. Watch it as a market barometer, not just a stock. And remember that even a strong debut isn't the end of the story: SpaceX's shares have swung sharply on hype since its listing, a reminder that the months after an IPO test the business, not the launch.
The Honest Risks
- ⚠️ Hot demand can reverse fast. IPOs priced into heavy demand often trade below their debut within months once the excitement fades and lock-ups expire.
- ⚠️ Secondary-heavy deal. 73% of the shares are existing investors selling. That's normal, but most of the money isn't going into the business.
- ⚠️ Profitable, but only just. A ~5% net margin, recent profitability, and a prospectus that warns there's no assurance it lasts. Oura also drew $375 million of debt partly to fund its pre-IPO buyback of early investors' shares.
- ⚠️ A rich valuation. Roughly 10 times trailing revenue for a company that still makes 80% of its money from hardware, with competition from Samsung, Whoop, Google and Apple, which is reportedly developing a screenless health band of its own.
- ⚠️ Legal cloud. A proposed class action over sleep-tracking accuracy (which Oura contests) is unresolved.
- ⚠️ You probably won't get the IPO price. Retail allocations are small; buying on day one at the market price is a different, riskier proposition.
The takeaway: four-times demand tells you Wall Street likes this deal, at this price, this week. It doesn't tell you whether Oura will be worth more in three years. The excitement is real and the business has genuine strengths, but oversubscription is a fact about the offering, not a verdict on the investment.
How to Buy Oura Stock on Nemo.money
Once Oura's shares start trading on the Nasdaq under the ticker OURA, you'll be able to buy them on the Nemo.money app, alongside thousands of US-listed stocks and ETFs. A few things worth knowing:
- Buy from Just $1: Fractional shares mean you don't need to buy a whole share, useful when a newly listed stock is volatile and you'd rather start small.
- Zero-Commission Trading: Buy and sell US-market stocks and ETFs without commission fees.
- Market price, not IPO price: Like most investing apps, Nemo doesn't offer IPO allocations, so you'd be buying once trading begins, at the market price, which can differ substantially from the IPO price in the early days.
- AI-Powered Insights & Nemes: Explore data, sentiment and curated themed collections (Nemes), including technology, health and wearables themes, as a research starting point.
- Earn 6% AER on Idle Cash: Uninvested cash in your wallet earns 6% AER, paid daily in USD, while you research and decide.
Being able to buy a stock isn't a reason to buy it: OURA is an example to research, not a recommendation, and your capital is at risk.
Frequently Asked Questions (FAQs)
What does it mean that Oura's IPO is oversubscribed?
It means investors placed orders for far more shares than are on offer, in Oura's case roughly four times the 50 million shares, according to Bloomberg. Oversubscription signals strong demand for the deal at the marketed price range. It usually leads the banks to price at the top of the range or above it, and it means allocations are cut, so most investors, especially retail investors, receive fewer shares than they asked for, or none. It measures demand on pricing day; it doesn't predict how the stock performs long term.
When does Oura start trading?
Oura is scheduled to set its final IPO price on Tuesday 29 September 2026, with shares expected to begin trading on the Nasdaq Global Select Market under the ticker OURA shortly afterwards, likely this week. Exact timing can shift, so check the latest listing details. Most ordinary investors buy once trading begins, at the market price, which can differ substantially from the IPO price, and early trading in new listings is often volatile.
Why is there so much demand for Oura's IPO?
Several factors: Oura arrives profitable ($60.8 million of net income over nine months), which is rare for consumer hardware; its subscription revenue is growing 121% a year at high margins; it has 5 million paid members, strong retention and around 79% of the smart-ring market; it has health-tech credibility, including Eli Lilly's involvement; and a quiet September IPO calendar, with no US listing over $1 billion since Jersey Mike's Subs in July, left it with the market's full attention. Retail access through Coinbase, Robinhood and SoFi has broadened demand further.
Does an oversubscribed IPO mean the stock will go up?
Not necessarily. Heavy demand often produces a first-day "pop," but that mostly benefits those who received shares at the IPO price. Many heavily oversubscribed IPOs have fallen below their debut price within months once initial excitement fades and insider lock-ups expire, while some quieter listings have performed well. Oversubscription is a fact about the offering, not a forecast for the business. Long-term returns depend on growth, profits and valuation.
Is Oura profitable?
Yes, on a net income basis. Oura's prospectus shows net income of $60.8 million on revenue of $1.21 billion for the nine months to 30 June 2026 (about a 5% margin), with $71.2 million of operating income and $328 million of operating cash flow. Profitability is recent: it roughly broke even in fiscal 2025 and earned $3.6 million in fiscal 2024, and the prospectus warns there's no assurance it will continue. The "$924 million loss" in some headlines is the loss attributable to common stockholders after a $985 million accounting charge (a "deemed dividend") from repurchasing early investors' preferred stock before the IPO. It is not an operating loss.
How can I buy Oura stock?
Once Oura completes its IPO and its shares begin trading on the Nasdaq under the ticker OURA, you can buy them through an investing app or brokerage that offers US-listed stocks. On Nemo.money, OURA will be available to buy from $1 (via fractional shares) with zero commission, once trading begins. You'd be buying at the market price rather than the IPO price, and newly listed shares are often volatile in the first days and weeks.
Can I buy Oura shares at the IPO price?
Only if you received an allocation through a broker participating in the offering (for this deal, platforms such as Coinbase, Robinhood and SoFi offered access). With demand at roughly four times the shares available, allocations are heavily cut and most retail applicants receive little or nothing. Otherwise, investors buy once trading begins, at the market price, which is where most ordinary investors end up.
Final Thoughts: Demand Is a Fact, Not a Forecast
Oura's four-times-oversubscribed IPO is a genuine moment: a profitable, fast-growing consumer-health company drawing the kind of demand Wall Street hasn't seen for a non-AI listing in months, with retail investors queuing up through apps that didn't offer IPO access a year ago. If it prices well and trades well, it may reopen the door for other companies waiting to list.
But the most useful thing an investor can take from "everyone wants in" is a clear head about what it does and doesn't mean. Oversubscription tells you the deal is popular at this price, this week. It tells you most people won't get shares at the IPO price, and that whoever buys on day one is paying whatever the crowd decides in the opening minutes. It tells you nothing about whether a ring-and-subscription business is worth $15 billion in three years. Oura has real strengths and real catches; the demand changes neither. Watch the debut with interest, then judge the business, not the queue.
Explore global stocks and ETFs from $1 with zero commission on the Nemo.money app.
Nemo = Never Miss Out.
Stay informed. Stay ahead.
#Oura #IPO #Investing #Wearables #NemoMoney
Terms and conditions apply. This is not investment advice. Past performance is not indicative of future results. Your capital is at risk. See website for Risk Disclosure. Exinity ME Ltd (https://nemo.money) is regulated by ADGM's Financial Services Regulatory Authority.
